285 related articles for article (PubMed ID: 8968547)
1. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
Webb TE; Feolde E; Vigne P; Neary JT; Runberg A; Frelin C; Barnard EA
Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
[TBL] [Abstract][Full Text] [Related]
2. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
Schäfer R; Reiser G
Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
Boyer JL; Zohn IE; Jacobson KA; Harden TK
Br J Pharmacol; 1994 Oct; 113(2):614-20. PubMed ID: 7834215
[TBL] [Abstract][Full Text] [Related]
4. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a P2Y purinoceptor in the brain.
Simon J; Webb TE; Barnard EA
Pharmacol Toxicol; 1995 May; 76(5):302-7. PubMed ID: 7567779
[TBL] [Abstract][Full Text] [Related]
6. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
Ho C; Hicks J; Salter MW
Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
[TBL] [Abstract][Full Text] [Related]
7. Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells.
Simon J; Filippov AK; Göransson S; Wong YH; Frelin C; Michel AD; Brown DA; Barnard EA
J Biol Chem; 2002 Aug; 277(35):31390-400. PubMed ID: 12080041
[TBL] [Abstract][Full Text] [Related]
8. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
Pintor J; Díaz-Rey MA; Miras-Portugal MT
Br J Pharmacol; 1993 Apr; 108(4):1094-9. PubMed ID: 8485620
[TBL] [Abstract][Full Text] [Related]
9. Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta.
Hansmann G; Bültmann R; Tuluc F; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):641-52. PubMed ID: 9402045
[TBL] [Abstract][Full Text] [Related]
10. Binding of [35S]adenosine 5'-O-(2-thiodiphosphate) to endothelial cells in culture.
Wilkinson GF; Boarder MR
Biochem Pharmacol; 1995 May; 49(10):1411-8. PubMed ID: 7763284
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of a recombinant P2Y purinoceptor.
Simon J; Webb TE; King BF; Burnstock G; Barnard EA
Eur J Pharmacol; 1995 Nov; 291(3):281-9. PubMed ID: 8719412
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.
Bültmann R; Dudeck O; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):445-51. PubMed ID: 8935712
[TBL] [Abstract][Full Text] [Related]
13. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
Mateo J; Miras-Portugal MT; Castro E
Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
[TBL] [Abstract][Full Text] [Related]
14. Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.
Najbar AT; Li CG; Rand MJ
Br J Pharmacol; 1996 Jun; 118(3):537-42. PubMed ID: 8762075
[TBL] [Abstract][Full Text] [Related]
15. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
Schachter JB; Li Q; Boyer JL; Nicholas RA; Harden TK
Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of adenylyl cyclase by neuronal P2Y receptors.
Unterberger U; Moskvina E; Scholze T; Freissmuth M; Boehm S
Br J Pharmacol; 2002 Feb; 135(3):673-84. PubMed ID: 11834615
[TBL] [Abstract][Full Text] [Related]
17. Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.
King BF; Dacquet C; Ziganshin AU; Weetman DF; Burnstock G; Vanhoutte PM; Spedding M
Br J Pharmacol; 1996 Mar; 117(6):1111-8. PubMed ID: 8882604
[TBL] [Abstract][Full Text] [Related]
18. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
19. ATP acting on P2Y receptors triggers calcium mobilization in primary cultures of rat neurohypophysial astrocytes (pituicytes).
Troadec JD; Thirion S; Petturiti D; Bohn MT; Poujeol P
Pflugers Arch; 1999 Apr; 437(5):745-53. PubMed ID: 10087153
[TBL] [Abstract][Full Text] [Related]
20. High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.
Michel AD; Humphrey PP
Br J Pharmacol; 1996 Jan; 117(1):63-70. PubMed ID: 8825344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
